Tirz Price: What Tirzepatide Costs in the US

Tirzepatide, commonly shortened to "tirz," typically costs between about $200 and $1,100 per month in the United States. Brand-name Zepbound lists for roughly $1,059 per month without insurance, while Eli Lilly's self-pay vials start near $349, and compounded versions have historically run $200 to $500. What you actually pay comes down to your dose, your insurance plan, and which pharmacy channel you use.

What "Tirz Price" Usually Means

"Tirz" is internet shorthand for tirzepatide, the active ingredient in Mounjaro and Zepbound. Mounjaro is FDA-approved for type 2 diabetes, and Zepbound is FDA-approved for chronic weight management in adults who meet specific criteria.

Because one drug is sold under two names, in six dose strengths, and through several channels, the tirz price people quote online can differ by hundreds of dollars per month. A starting-dose vial bought with cash and a 15 mg pen processed through insurance are not comparable purchases, even though both contain tirzepatide.

Searches for "tirz weight loss price" usually mean the cash price of Zepbound or a compounded alternative, while "tirz for sale" searches often lead to gray-market sellers. Tirzepatide is a prescription drug in the United States, and no legitimate seller can ship it to you without a valid prescription.

Tirzepatide Price by Source

Most US buyers fall into one of these five buckets. The ranges below are approximate and change frequently, so confirm current pricing with the pharmacy or program directly.

Source	Typical monthly cost	What you get	Key notes
Brand-name pen, cash	$1,000-$1,100	Four weekly pens	List price before any discount or insurance
LillyDirect self-pay vials	$349-$499	Single-dose vials plus syringes	2.5 mg around $349; higher doses around $499
Insurance plus savings card	$25-$150	Brand-name pen	Requires commercial coverage and eligibility
Compounded tirzepatide	$200-$500	Vial plus syringes	Not FDA-approved; availability now restricted
Clinical trial	$0	Study drug or placebo	Must meet enrollment criteria

Dose affects price differently depending on the channel. Brand-name pens cost the same at every dose, but compounded and vial-based pricing sometimes scales with milligrams, so moving up a dose can raise your bill.

Does Insurance Cover Tirzepatide?

Coverage depends on the diagnosis written on the prescription more than on the drug itself. Many commercial plans cover Mounjaro for type 2 diabetes after a prior authorization, while Zepbound for weight loss is covered far less often.

Medicare Part D cannot cover tirzepatide when it is prescribed for weight loss, so Medicare beneficiaries generally pay cash unless they have another qualifying diagnosis. Medicaid coverage is decided state by state.

When a plan does cover tirzepatide, manufacturer savings cards can reduce the copay to as little as $25 per month for eligible commercially insured patients. Government-insured patients usually do not qualify for those cards.

Ways to Lower the Tirz Price

1. Use the self-pay vial program. LillyDirect sells single-dose Zepbound vials for roughly $349 at the starting dose and about $499 at higher doses.
2. Read the savings card rules. Cards often require commercial insurance and a denied or partial claim before they apply.
3. Compare pharmacies. Cash prices for the same pen can vary by $100 or more between chains.
4. Ask about a 90-day fill. Some plans reduce copays for longer fills.
5. Consider a clinical trial. Trial participants receive study medication at no cost, though they may receive a placebo.
6. Ask your prescriber about alternatives. Other FDA-approved options may cost less under your specific plan.

Anyone shopping around tends to check several categories at once. Searchers comparing injectables often jump between unrelated products, looking up a lipo-c injection price one week and a mots-c peptide price the next, even though those products are not tirzepatide and are not FDA-approved for weight loss.

Compounded Tirzepatide: Still an Option?

Compounded tirzepatide grew popular while the brand-name drug was on the FDA shortage list and supply was tight. The FDA has since resolved that shortage, and large-scale compounding of tirzepatide is no longer permitted under the usual rules, though a limited number of state-licensed pharmacies operate under narrow exceptions.

Compounded drugs are not FDA-approved, so they do not carry the same guarantees for strength, purity, or sterility as Zepbound or Mounjaro. Prices historically ran $200 to $500 per month, and some telehealth companies bundled the drug with a monthly membership fee.

Other Injectables People Price-Check

Demand for weight-loss and wellness injections has pushed shoppers into unrelated markets. Anyone who looks up the retatrutide price in usa without insurance should know that retatrutide is not FDA-approved and remains an investigational drug in Phase 3 trials.

Vendors advertising a synedica retatrutide price, or any similar listing, are offering an unapproved product with no guarantee of identity or sterility. The same caution applies to "research grade" peptides sold with disclaimers that say "not for human use."

Safety and Cost Traps to Avoid

Cheap tirzepatide is often not tirzepatide. Unverified websites, social media sellers, and pop-up telehealth sites may ship vials with no lot number, no pharmacy license, and no way to trace what is inside.

• Buy only from a licensed US pharmacy with a valid prescription.
• Refuse products labeled "for research use only."
• Be skeptical of prices far below $200 per month.
• Expect side effects such as nausea, vomiting, and diarrhea, and report severe ones to a clinician.

Tirzepatide can cause serious gastrointestinal effects and is not appropriate for people with a personal or family history of medullary thyroid cancer or MEN2. Talk with a healthcare professional before starting, stopping, or switching products.

Tirzepatide prices have fallen since 2024 and manufacturer programs change often, so recheck the numbers before you commit to a monthly plan.

COMMON QUESTIONS

Frequently Asked Questions

How much does tirzepatide cost per month without insurance?

Brand-name Zepbound pens list for about $1,059 per month without insurance. Eli Lilly's self-pay vial program is cheaper, at roughly $349 for the 2.5 mg dose and about $499 for higher doses. Compounded tirzepatide historically ranged from $200 to $500 per month before compounding restrictions tightened.

Is compounded tirzepatide still available in the United States?

Large-scale compounding of tirzepatide is no longer permitted under the usual rules because the FDA resolved the brand-name shortage. A limited number of state-licensed pharmacies may still prepare it under narrow exceptions. Compounded tirzepatide is not FDA-approved and does not carry the same quality guarantees as Zepbound or Mounjaro.

Does insurance cover tirzepatide for weight loss?

Coverage varies widely by plan and by diagnosis. Many commercial plans cover Mounjaro for type 2 diabetes with prior authorization, but Zepbound for weight loss is covered less often. Medicare Part D is prohibited from covering tirzepatide when it is prescribed for weight loss.